Clene Inc. (CLNN) stock
CLNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.22−0.44 (-12.02%)
Close on Nov 17, 2026Market cap $41.37MP/E –Yield –
Clene operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Clene's operating cash flow for the twelve months ending Jun 30, 2026 was -$15.91M. For fiscal 2025 it was -$18.55M. The highest annual figure on record is -$13.20M in fiscal 2019.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$18.55M | – |
| FY2024 | Dec 31, 2024 | -$21.33M | – |
| FY2023 | Dec 31, 2023 | -$30.17M | – |
| FY2022 | Dec 31, 2022 | -$39.01M | – |
| FY2021 | Dec 31, 2021 | -$34.62M | – |
| FY2020 | Dec 31, 2020 | -$18.93M | – |
| FY2019 | Dec 31, 2019 | -$13.20M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.59M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.53M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.80M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.99M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.74M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.01M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.87M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.02M | – |
| Q2 FY2024 | Jun 30, 2024 | -$6.36M | – |
| Q1 FY2024 | Mar 31, 2024 | -$7.08M | – |
| Q4 FY2023 | Dec 31, 2023 | -$7.17M | – |
| Q3 FY2023 | Sep 30, 2023 | -$6.76M | – |
| Q2 FY2023 | Jun 30, 2023 | -$7.02M | – |
| Q1 FY2023 | Mar 31, 2023 | -$9.22M | – |
| Q2 FY2022 | Jun 30, 2022 | -$9.73M | – |
| Q1 FY2022 | Mar 31, 2022 | -$13.08M | – |
| Q4 FY2021 | Dec 31, 2021 | -$9.61M | – |
| Q3 FY2021 | Sep 30, 2021 | -$7.31M | – |
| Q2 FY2021 | Jun 30, 2021 | -$8.55M | – |
| Q1 FY2021 | Mar 31, 2021 | -$9.16M | – |
| Q4 FY2020 | Dec 31, 2020 | -$5.81M | – |
| Q3 FY2020 | Sep 30, 2020 | -$7.72M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.15M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.25M | – |
See a number that looks wrong?